Cargando…
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
EpCAM expressing circulating tumor cells, detected by CellSearch, are predictive of short survival in several cancers and may serve as a liquid biopsy to guide therapy. Here we investigate the presence of EpCAM(+) CTC detected by CellSearch and EpCAM(–) CTC discarded by CellSearch, after EpCAM based...
Autores principales: | Wit, Sanne de, Dalum, Guus van, Lenferink, Aufried T. M., Tibbe, Arjan G. J., Hiltermann, T. Jeroen N., Groen, Harry J. M., van Rijn, Cees J. M., Terstappen, Leon W. M. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505332/ https://www.ncbi.nlm.nih.gov/pubmed/26184843 http://dx.doi.org/10.1038/srep12270 |
Ejemplares similares
-
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients
por: de Wit, Sanne, et al.
Publicado: (2018) -
Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment
por: Nanou, Afroditi, et al.
Publicado: (2019) -
Expression of EpCAM in uveal melanoma
por: Odashiro, Danilo N, et al.
Publicado: (2006) -
Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)